Ghana News
How Ghana Is Working With WHO and CDC to Stop Hantavirus Before It Arrives
No cases have been recorded on its soil, but Ghana is not waiting for Hantavirus to arrive.
Instead, the Ghana Health Service (GHS) has activated a multi-layered response in close collaboration with the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC), following a deadly outbreak on a cruise ship docked in Cape Verde.
The outbreak, which as of May 7, 2026, has infected at least eight people, with five confirmed cases and three deaths, has triggered global concern. The affected vessel carried crew members primarily from the Philippines and passengers from the United States, Europe, South America, Australia, and parts of Asia.
Although the WHO and CDC have assessed the overall global public health risk as low, both agencies have advised nations to strengthen surveillance and preparedness. Ghana has responded by turning that advice into action.
A Coordinated International Response
At the heart of Ghana’s strategy is a three-part partnership: the WHO provides global epidemiological data and technical guidance; the CDC supplies risk assessment frameworks and laboratory protocols; and the Ghana Health Service executes on-the-ground measures tailored to the country’s ports, health facilities, and communities.
“The WHO and CDC, after risk assessment, have indicated that the overall global public health risk remains low. However, countries have been advised to strengthen surveillance and preparedness systems,” the GHS noted in its official press statement (published further down in this story).
Ghana has taken that advisory as a mandate for immediate action.
The Ministry of Health and the GHS are now collaborating with international partners, including the WHO and global disease surveillance networks, to ensure timely sharing of information. This real-time data exchange allows Ghana to adjust its protocols as the situation in Cape Verde evolves.
On the Ground: Enhanced Surveillance at All Ports of Entry
Ghana’s first line of defense is its Port Health Division. Enhanced surveillance has been deployed at all ports of entry, including the Kotoka International Airport in Accra, as well as the seaports at Tema and Takoradi. Health officials are screening travelers for symptoms consistent with Hantavirus, fever, headache, muscle pain, abdominal discomfort, vomiting, and in severe cases, difficulty breathing.
The GHS has also directed health facilities nationwide to intensify monitoring and reporting of unusual respiratory illnesses. Any patient presenting with fever and breathing difficulties, especially with a travel history to Cape Verde or potential rodent exposure, will trigger an alert protocol.
Strengthening Laboratory and Response Capacity
Recognizing that a threat is only as manageable as the ability to detect it, Ghana is strengthening its laboratory systems and rapid response capacity. The GHS is working with WHO and CDC reference labs to ensure that any suspected sample can be tested quickly and accurately. While Hantavirus is not yet in Ghana, the infrastructure being reinforced will also benefit responses to other emerging pathogens.
Rapid response teams have been placed on standby, equipped with protective gear and trained in safe isolation and transport procedures. The GHS has assured citizens that the country’s disease surveillance systems remain “active and capable” of responding to any potential threat.
Public Education: Rodent Control and Hygiene
Because Hantavirus is transmitted mainly through contact with infected rodents or exposure to their droppings, urine, saliva, or contaminated surfaces, Ghana’s prevention strategy extends beyond ports and hospitals. The GHS is stepping up public education on sanitation and rodent control.
Residents are being advised to maintain proper hygiene, keep their surroundings clean, store food safely, dispose of waste properly, and avoid direct contact with rodents and their droppings. For those cleaning potentially contaminated areas, the use of protective gear—gloves, masks, and disinfectants—is strongly urged.
“Members of the public are advised to maintain proper hygiene, keep their surroundings clean, store food safely, dispose of waste properly, and avoid contact with rodents and their droppings,” the GHS statement stressed.
Why Ghana Is Not Waiting
Hantavirus is not new to science, but its appearance on a cruise ship in Cape Verde represents a novel pathway for regional spread. The virus does not transmit between humans easily; rather, it is typically acquired from rodent hosts. However, international travel and shipping can move infected rodents or contaminated materials across borders quickly.
Ghana’s proactive stance reflects lessons learned from past outbreaks, including Ebola and COVID-19. Waiting for a first case before activating full preparedness measures has proven costly elsewhere. By acting now, in partnership with the WHO and CDC, Ghana aims to ensure that “Hantavirus arrives” remains a hypothetical, not a headline.
Advice to the Public and Travelers
The GHS and Ministry of Health have urged the public to remain calm, avoid misinformation, and rely on official health updates. Travelers to Cape Verde or anyone returning from the region are advised to seek immediate medical attention if they develop fever or breathing difficulties, especially after possible rodent exposure.
For now, Ghana’s ports remain open, its health facilities are on alert, and its international partnerships are fully engaged. As the GHS put it: “No case of Hantavirus has been recorded in Ghana. Nonetheless, precautionary measures have been activated.”
That careful balance, vigilance without panic, action without alarm, defines Ghana’s approach to stopping Hantavirus before it arrives.
Ghana News
Ghanaian Firms Inject €425,000 of Own Funds to Ignite ‘Made in Ghana’ Health Innovation
In a powerful demonstration of local ownership, Ghanaian research institutions and pharmaceutical manufacturers are contributing an additional €425,000 of their own money to implement innovative health projects, signaling a robust commitment to advancing homegrown medical solutions beyond relying on foreign aid alone.
The co-funding is part of a €2 million grant package awarded under the PharmaVax Ghana program, backed by the German Federal Ministry for Economic Cooperation and Development (BMZ) and the European Union (EU).
The initiative is designed to bridge the critical gap between scientific discovery and industrial-scale manufacturing within Ghana.
While the grants provide vital financial fuel, the local co-investment—which ranges from €10,000 to €150,000 across the eight winning projects—represents a crucial “skin in the game” approach.
It shows that local institutions are not merely passive recipients of aid, but active stakeholders willing to risk their own capital to bring products to the market. This practical commitment underscores the sustainability of the projects, ensuring they are not abandoned once international funding cycles end.
The projects span a wide range of medical priorities, including fast-dissolving oral tablets for child-friendly malaria treatment, AI-powered diagnostic tools for Mpox and malaria, standardized herbal treatments for hypertension and liver disease, and stability data for locally produced tetanus-diphtheria vaccines.
Highlighting the importance of this local participation, Dr. Sodzi Sodzi-Tettey, Chief Executive Officer of the National Vaccine Institute (NVI), emphasized that the funds are meant to catalyze local capabilities.
“Ghana has the scientific talent, the research institutions and an increasingly capable pharmaceutical industry to develop health solutions that respond to our own priorities,” he stated. “By bringing these strengths together, we are creating the foundation for medicines and vaccines that are developed in Ghana, manufactured in Ghana, and have the potential to benefit the wider region.”
Ghana’s Minister of Health, Hon. Kwabena Mintah Akandoh, echoed this sentiment, noting that the initiative marks a journey where researchers and manufacturers collaborate to transform scientific discoveries into life-saving products.
The €425,000 in local contributions—combined with the €2 million in grants and technical assistance from the EU and Germany—positions Ghana as a rising hub for pharmaceutical industrialization in West Africa, moving the nation closer to health security and economic self-reliance.
Ghana News
From Default to Discipline: How Ghana is Legally Binding Itself to Prevent the Next Debt Crisis
Fresh off a landmark agreement with Belgium that eases its debt burden, Ghana’s Finance Minister, Dr. Cassiel Ato Forson, has unveiled a sweeping package of legal and institutional reforms designed to permanently prevent the country from sliding back into the fiscal chaos that triggered its 2022 sovereign default.
The deal with Belgium to restructure €163 million in debt owed to the country’s Export Credit Agency marks a pivotal step towards completing Ghana’s broader debt restructuring program. Crucially, the agreement frees up much-needed “fiscal space” by slashing the amount of national revenue consumed by debt servicing. Minister Forson revealed that Ghana’s debt-service burden has fallen drastically from a crippling peak of roughly 50% to 55% of national revenue to less than 20% today—a shift that directly impacts the government’s ability to fund schools, hospitals, and roads.
However, the most significant aspect of Ghana’s strategy is its attempt to codify fiscal prudence into law, ensuring that the discipline learned from the crisis is not lost by future administrations.
A Three-Pronged Strategy for Fiscal Discipline
1. The Commitment Authorization Regime
At the core of the immediate controls is a strict mandate for all Ministries, Departments, and Agencies (MDAs). Under the amended Public Financial Management Act, no government institution can initiate a contract for goods, services, or works without first securing commitment authorization from the Finance Minister . This process, integrated with the Ghana Integrated Financial Management Information System (GIFMIS), acts as a “roadblock” to prevent overspending and the accumulation of hidden arrears—a practice that historically poisoned the country’s finances.
2. Binding Fiscal Rules in Law
Beyond day-to-day controls, the government has instituted statutory targets to ensure long-term solvency. The Public Financial Management Act has been amended to require a minimum annual primary surplus of 1.5% of GDP and to cap the national debt-to-GDP ratio at 45% by 2034 . These are not policy recommendations but binding legal requirements, with the Finance Minister potentially facing censure for breaching these targets.
3. Independent Oversight Institutions
To guarantee that fiscal responsibility is maintained even after Ghana concludes its International Monetary Fund (IMF) programme, the government has established two powerful oversight bodies:
- The Value for Money Office: Parliament passed the Value-for-Money Office Bill in March 2026, creating an independent body to scrutinize major public expenditure. This office will combat inflated contracts, cost overruns, and abandoned projects by issuing mandatory “Value for Money Certificates” before major contracts are awarded.
- The Independent Fiscal Council: The government is establishing a council composed of locally appointed experts to provide advisory support on financial controls and fiscal decision-making . This council, scheduled to take effect after the IMF programme ends, aims to strengthen domestic oversight and accountability, ensuring that Ghana owns its fiscal destiny.
From Recovery to Sustainability
Finance Minister Ato Forson is clear about the goal: “We want to ensure that the fiscal rules that we have instituted today are enshrined in law, so that even if this government is not there, the next government will have to make sure that these fiscal rules are respected” .
The Belgium agreement is the immediate piece of good news that provides tangible relief—allowing Ghana to redirect more resources towards essential public services. But the real measure of Ghana’s recovery will be its ability to enforce these new legal shackles.
By moving from crisis management to institutionalized discipline, Ghana is attempting to break the cycle of over-borrowing, arrears, and economic collapse that has plagued the nation for decades.
Ghana News
EU and Germany Inject €2 Million into Ghana to Boost ‘Made in Africa’ Pharma Production
In a significant boost to Africa’s push for pharmaceutical self-reliance, the European Union (EU) and Germany have injected €2 million into Ghana to bridge the critical gap between laboratory research and industrial-scale manufacturing.
The funding, awarded under the PharmaVax Ghana programme, has been distributed to eight groundbreaking research partnerships aimed at developing and manufacturing medicines and vaccines locally, drastically reducing the continent’s historical reliance on imported drugs.
The announcement came during the “Research Meets Manufacturing” Award Ceremony in Accra on August 19, co-hosted by Ghana’s National Vaccine Institute (NVI) and the German development agency GIZ.
The grants are jointly funded by the German Federal Ministry for Economic Cooperation and Development (BMZ) and the European Union (EU) as part of the broader Team Europe Initiative on Manufacturing and Access to Vaccines, Medicines and Health Technologies in Africa (MAV+).
This strategic geopolitical and economic move underscores Western Europe’s commitment to backing local African manufacturing ecosystems, countering the long-standing structural imbalance where Africa imports over 90% of its pharmaceuticals.
“A ceremony marks the beginning of an important journey—a journey that brings researchers, manufacturers, government and international partners together to transform scientific discoveries into medicines and vaccines that save and improve lives,” said Hon. Kwabena Mintah Akandoh, Ghana’s Minister of Health, during the event.
Innovation Across the Health Spectrum
The eight winning projects, selected from 43 competitive proposals by an independent committee of nine Ghanaian experts, represent the breadth of the nation’s scientific talent. They include:
- AI-driven monoclonal antibodies and diagnostics for Mpox and malaria, using a Ghanaian artificial intelligence platform.
- Fast-dissolving oral tablets for the treatment of malaria in children, addressing critical issues of accurate dosing.
- Clinical trials for locally developed herbal treatments for prostate health, hypertension, and alcohol-related liver disease.
- Stability data generation to support regulatory approval of locally produced tetanus-diphtheria vaccines, snake venom antiserum, and pain management therapies.
A Foundation for Health Sovereignty
Dr. Sodzi Sodzi-Tettey, Chief Executive Officer of the National Vaccine Institute, emphasized that the grants go far beyond financial aid.
“Ghana has the scientific talent, the research institutions and an increasingly capable pharmaceutical industry to develop health solutions that respond to our own priorities,” Dr. Sodzi-Tettey stated. “By bringing these strengths together, we are creating the foundation for medicines and vaccines that are developed in Ghana, manufactured in Ghana, and have the potential to benefit the wider region.”
Notably, Ghanaian partners are contributing an additional €425,000 towards implementing their projects, demonstrating a strong local commitment to advancing homegrown innovation. Alongside the direct funding, the projects will also receive technical assistance, networking opportunities, and knowledge exchange to ensure long-term commercial viability.
As the global health community increasingly looks to localized manufacturing to secure supply chains, this €2 million initiative serves as a pivotal case study.
It represents a concrete, actionable blueprint for how international development capital can ignite the “Made in Africa” pharmaceutical industrial wave, securing the continent’s health security and driving economic development from within.
Ghanaian Firms Inject €425,000 of Own Funds to Ignite ‘Made in Ghana’ Health Innovation
From Default to Discipline: How Ghana is Legally Binding Itself to Prevent the Next Debt Crisis
